A fluorescence-based assay is used to screen cyclic peptides for their activity in preventing protein misfolding, an event that can generate pathogenic aggregates that lead to diseases such as Alzheimer’s disease or amyotrophic lateral sclerosis..
- Ilias Matis
- Dafni Chrysanthi Delivoria
- Georgios Skretas
